title: Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts.
authors.forename: J S
authors.initials: JS
authors.lastname: Wiley
authors.forename: G P
authors.initials: GP
authors.lastname: Jamieson
authors.forename: J S
authors.initials: JS
authors.lastname: Cebon
authors.forename: R K
authors.initials: RK
authors.lastname: Woodruff
authors.forename: J J
authors.initials: JJ
authors.lastname: McKendrick
authors.forename: J
authors.initials: J
authors.lastname: Szer
authors.forename: J
authors.initials: J
authors.lastname: Gibson
authors.forename: W P
authors.initials: WP
authors.lastname: Sheridan
authors.forename: J C
authors.initials: JC
authors.lastname: Biggs
authors.forename: M C
authors.initials: MC
authors.lastname: Rallings
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects*; D006098:Granulocytes / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008171:Lung Diseases / Q000209:etiology*; D008875:Middle Aged
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor